6 Matching Annotations
  1. Jul 2026
  2. www.sciencedirect.com www.sciencedirect.com
    Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379126003393
  3. Apr 2026
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13198247/
  5. Aug 2024
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11319797/
  7. Jul 2024
  8. www.embopress.org www.embopress.org
    DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    embopress.org/doi/10.1038/s44321-024-00097-z
  9. May 2024
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Inhibition of NAD+-dependent metabolic processes induces cellular necrosis and tumor regression in rhabdomyosarcoma models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10841338/
  11. Jan 2023
  12. www.biorxiv.org www.biorxiv.org
    DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.01.08.523169v1